The impacts of national centralized drug procurement policy on drug utilization of medical institutions: an empirical study in a county-level hospital in China.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Drug Utilization*/statistics & numerical data; China ; Humans ; Health Policy ; Hospitals, County/statistics & numerical data
    • Abstract:
      Purpose: Under the background of the regular implementation of the National Centralized Drug Procurement (NCDP) policy, this study aimed to assess the impacts of the NCDP policy on drug utilization of county-level medical institutions, and probe into the influencing factors of the changes in drug utilization.
      Method: A pre-post study was applied using inpatient data from a county-level medical institution in Nanjing. Drug utilization behavior of medical institutions of 88 most commonly used policy-related drugs (by generic name, including bid-winning and bid-non-winning brands) was analyzed, and the substitution of bid-winning brands for brand-name drugs after policy intervention was evaluated.
      Results: After policy intervention, 43.18% of policy-related drugs realized the substitution of bid-winning brands for bid-non-winning brands (6.82% of complete substitution, 36.36% of partial substitution). Meanwhile, 40.90% of policy-related drugs failed to realize brand substitution. Multiple factors affected brand substitution, including: (1) Policy effect: brand substitution was more obvious after the intervention of the first and third round of NCDP. (2) Drug market competition: the greater the price reduction of bid-non-winning brands, the more the drugs for the same indication, the more likely that medical institutions keep using the same brands as they did before policy intervention. (3) Previous drug utilization of medical institutions: brand substitution was more obvious in drugs with large number of prescriptions and weak preference for brand-name drugs.
      Conclusion: The NCDP policy promoted the substitution of bid-winning brands for bid-non-winning brands. However, the NCDP policy remained to be further implemented in county-level medical institutions. Policy implememtation efforts, drug market competition and drug utilization of medical institutions would affect the implementation of the NCDP policy.
      (© 2024. The Author(s).)
    • References:
      BMC Health Serv Res. 2021 Jul 8;21(1):668. (PMID: 34238290)
      Int J Health Plann Manage. 2022 May;37(3):1650-1662. (PMID: 35132676)
      BMC Health Serv Res. 2021 Nov 26;21(1):1275. (PMID: 34823516)
      BMJ Open. 2021 Oct 18;11(10):e051277. (PMID: 34663661)
      BMJ Open. 2022 Mar 14;12(3):e054346. (PMID: 35288385)
    • Contributed Indexing:
      Keywords: County-level hospital; Drug utilization; Influencing factors; National centralized drug procurement policy
    • Publication Date:
      Date Created: 20240424 Date Completed: 20240425 Latest Revision: 20240427
    • Publication Date:
      20240427
    • Accession Number:
      PMC11040739
    • Accession Number:
      10.1186/s12913-024-10964-7
    • Accession Number:
      38658940